Room for improvement: diagnosing and managing acute coronary syndromes in persons with reduced eGFR

Kerry L Horne; Maarten W Taal; Nicholas M Selby

doi:10.1016/j.kint.2022.04.017

Room for improvement: diagnosing and managing acute coronary syndromes in persons with reduced eGFR

Kidney Int. 2022 Jul;102(1):20-22. doi: 10.1016/j.kint.2022.04.017.

Authors

Kerry L Horne¹, Maarten W Taal¹, Nicholas M Selby²

Affiliations

¹ Centre for Kidney Research and Innovation, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK; Department of Renal Medicine, Royal Derby Hospital, Derby, UK.
² Centre for Kidney Research and Innovation, Academic Unit of Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK; Department of Renal Medicine, Royal Derby Hospital, Derby, UK. Electronic address: [email protected].

PMID: 35738829
DOI: 10.1016/j.kint.2022.04.017

Abstract

Cardiovascular events are the leading cause of death in chronic kidney disease. A recent analysis from the High-Sensitivity Troponin in the Evaluation of Patients With Suspected Acute Coronary Syndrome trial focused on results in those with reduced estimated glomerular filtration rate. This commentary discusses aspects of acute coronary syndrome diagnosis in this group and the differential approach to acute coronary syndrome management that was observed between those with normal and reduced kidney function.

Publication types

Comment

MeSH terms

Acute Coronary Syndrome* / diagnosis
Acute Coronary Syndrome* / therapy
Glomerular Filtration Rate
Humans
Renal Insufficiency*
Renal Insufficiency, Chronic* / diagnosis
Renal Insufficiency, Chronic* / therapy